We are live on ! Find out more
DTC

Deep Track Capital Portfolio holdings

AUM $6.12B
1-Year Est. Return 144%
This Fund
S&P 500
This Quarter Est. Return
+3.27%
1 Year Est. Return
+144%
3 Year Est. Return
+348.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.42B
AUM Growth
–
Cap. Flow
+$1.49B
Cap. Flow %
104.89%
Top 10 Hldgs %
42.68%
Holding
55
New
55
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$69M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$65.7M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$65.6M
4
KROS icon
Keros Therapeutics
KROS
+$64.8M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$62M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.41%
2 Real Estate 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KROS icon
1
Keros Therapeutics
KROS
$197M
$76.1M 5.37%
+1,300,000
New +$64.8M
TVTX icon
2
Travere Therapeutics
TVTX
$5.12B
$76M 5.37%
+2,450,000
New +$69M
BCYC
3
Bicycle Therapeutics
BCYC
$269M
$67M 4.73%
+1,100,000
New +$60.7M
ISEE
4
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$66.9M 4.72%
+4,000,000
New +$65.6M
JAZZ icon
5
Jazz Pharmaceuticals
JAZZ
$16.1B
$63.7M 4.5%
+500,000
New +$65.7M
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
$58.5M 4.13%
+2,000,000
New +$62M
BEAM icon
7
Beam Therapeutics
BEAM
$2.68B
$55.8M 3.94%
+700,000
New +$59.9M
CRNX icon
8
Crinetics Pharmaceuticals
CRNX
$8.88B
$54M 3.81%
+1,900,000
New +$46.8M
RPTX
9
DELISTED
Repare Therapeutics
RPTX
$44.3M 3.13%
+2,100,000
New +$49.5M
MDGL icon
10
Madrigal Pharmaceuticals
MDGL
$12.4B
$42.4M 2.99%
+500,000
New +$41.1M
FDMT icon
11
4D Molecular Therapeutics
FDMT
$496M
$41.7M 2.94%
+1,900,000
New +$46.6M
NVCR icon
12
NovoCure
NVCR
$1.78B
$41.3M 2.92%
+550,000
New +$55.2M
IMVT icon
13
Immunovant
IMVT
$7.8B
$40.7M 2.87%
+4,775,000
New +$39.4M
KDNY
14
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$39.5M 2.79%
+2,420,502
New +$34.5M
KURA icon
15
Kura Oncology
KURA
$786M
$35.7M 2.52%
+2,550,000
New +$41.3M
DICE
16
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$33.9M 2.4%
+1,341,004
New +$39.3M
JNCE
17
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$33.4M 2.36%
+4,000,000
New +$33M
ESPR
18
DELISTED
Esperion Therapeutics
ESPR
$28.2M 1.99%
+5,641,668
New +$45.2M
DYN icon
19
Dyne Therapeutics
DYN
$4.1B
$27.3M 1.92%
+2,292,250
New +$32.2M
VRDN icon
20
Viridian Therapeutics
VRDN
$2.14B
$26.4M 1.87%
+1,336,690
New +$24.9M
FATE icon
21
Fate Therapeutics
FATE
$267M
$24.5M 1.73%
+418,037
New +$23.7M
RNAM
22
DELISTED
Avidity Biosciences
RNAM
$23.8M 1.68%
+1,000,000
New +$23.9M
ACAD icon
23
CALL
Acadia Pharmaceuticals
ACAD
$4.46B
$23.3M 1.65%
+1,000,000
New +$20.1M
GRTS
24
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$22.8M 1.61%
+1,771,801
New +$19.6M
SLN
25
Silence Therapeutics
SLN
$537M
$22.7M 1.6%
+950,798
New +$22M
1
2 3

Similar funds

AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

Deep Track Capital's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Deep Track Capital, which disclosed 55 positions worth $1.42B. Its ten largest holdings account for 43% of the portfolio.

Its largest position is Travere Therapeutics: 2,450,000 shares worth $76M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Real Estate.

  • Deep Track Capital's largest Q4 2021 buy was Travere Therapeutics: 2,450,000 shares worth $76M.
  • Deep Track Capital's ten largest holdings make up 43% of its $1.42B portfolio in Q4 2021.
  • Deep Track Capital disclosed 55 positions in Q4 2021, its first 13F filing on record.

Based on Deep Track Capital's 13F filing for Q4 2021, filed 14 Feb 2022.